These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 32618402)

  • 21. Safety of Apremilast in Patients with Psoriasis and Psoriatic Arthritis: Findings from the UK Clinical Practice Research Datalink.
    Persson R; Cordey M; Paris M; Jick S
    Drug Saf; 2022 Nov; 45(11):1403-1411. PubMed ID: 36151359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apremilast efficacy and safety in a psoriatic arthritis patient affected by HIV and HBV virus infections.
    Manfreda V; Esposito M; Campione E; Bianchi L; Giunta A
    Postgrad Med; 2019 Apr; 131(3):239-240. PubMed ID: 30700196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Gastrointestinal side effects of apremilast : Characterization and management].
    Pinter A; Beigel F; Körber A; Homey B; Beissert S; Gerdes S; Staubach-Renz P; Radtke MA; Mössner R
    Hautarzt; 2019 May; 70(5):354-362. PubMed ID: 30937481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Doney L; Dressler C; Hua C; Hughes C; Naldi L; Afach S; Le Cleach L
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD011535. PubMed ID: 33871055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relative efficacy and safety of apremilast, secukinumab, and ustekinumab for the treatment of psoriatic arthritis.
    Song GG; Lee YH
    Z Rheumatol; 2018 Sep; 77(7):613-620. PubMed ID: 28791450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apremilast increases IL-10-producing regulatory B cells and decreases proinflammatory T cells and innate cells in psoriatic arthritis and psoriasis.
    Mavropoulos A; Zafiriou E; Simopoulou T; Brotis AG; Liaskos C; Roussaki-Schulze A; Katsiari CG; Bogdanos DP; Sakkas LI
    Rheumatology (Oxford); 2019 Dec; 58(12):2240-2250. PubMed ID: 31209492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-world biologic and apremilast treatment patterns in patients with psoriasis and psoriatic arthritis.
    Feldman SR; Zhang J; Martinez DJ; Lopez-Gonzalez L; Hoit Marchlewicz E; Shrady G; Zhao Y; Mendelsohn AM
    Dermatol Online J; 2021 Sep; 27(9):. PubMed ID: 34755976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Off-label studies on apremilast in dermatology: a review.
    Maloney NJ; Zhao J; Tegtmeyer K; Lee EY; Cheng K
    J Dermatolog Treat; 2020 Mar; 31(2):131-140. PubMed ID: 30935262
    [No Abstract]   [Full Text] [Related]  

  • 29. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real life experience of apremilast in psoriasis and arthritis psoriatic patients: Preliminary results on metabolic biomarkers.
    Mazzilli S; Lanna C; Chiaramonte C; Cesaroni GM; Zangrilli A; Palumbo V; Cosio T; Dattola A; Gaziano R; Galluzzo M; Chimenti MS; Gisondi P; Bianchi L; Campione E
    J Dermatol; 2020 Jun; 47(6):578-582. PubMed ID: 32239555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early and sustained efficacy with apremilast monotherapy in biological-naïve patients with psoriatic arthritis: a phase IIIB, randomised controlled trial (ACTIVE).
    Nash P; Ohson K; Walsh J; Delev N; Nguyen D; Teng L; Gómez-Reino JJ; Aelion JA;
    Ann Rheum Dis; 2018 May; 77(5):690-698. PubMed ID: 29343507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apremilast for the treatment of psoriatic arthritis.
    Varada S; Tintle SJ; Gottlieb AB
    Expert Rev Clin Pharmacol; 2014 May; 7(3):239-50. PubMed ID: 24702658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apremilast mechanism of action and application to psoriasis and psoriatic arthritis.
    Schafer P
    Biochem Pharmacol; 2012 Jun; 83(12):1583-90. PubMed ID: 22257911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apremilast for the treatment of psoriatic arthritis.
    Souto A; Gómez-Reino JJ
    Expert Rev Clin Immunol; 2015; 11(12):1281-90. PubMed ID: 26503917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimizing care for psoriatic patients requiring systemic therapies: how will COVID-19 disease transform risk perceptions?
    Talamonti M; Tofani L; Bianchi L; Galluzzo M
    Arch Dermatol Res; 2021 Mar; 313(2):127-128. PubMed ID: 32647977
    [No Abstract]   [Full Text] [Related]  

  • 36. Psoriatic patients with a history of cancer: A real-life experience with Apremilast treatment for 104 weeks.
    Bernardini N; Skroza N; Marchesiello A; Mambrin A; Proietti I; Tolino E; Maddalena P; Marraffa F; Rossi G; Volpe S; Potenza C
    Dermatol Ther; 2022 Oct; 35(10):e15306. PubMed ID: 35100460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis.
    Gisondi P; Girolomoni G
    Drug Des Devel Ther; 2016; 10():1763-70. PubMed ID: 27307707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Use of Apremilast in Psoriasis: A Delphi Study.
    Carrascosa JM; Belinchón I; Rivera R; Ara M; Bustinduy M; Herranz P
    Actas Dermosifiliogr (Engl Ed); 2020 Mar; 111(2):115-134. PubMed ID: 31864537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complete resolution of erythrodermic psoriasis with first-line apremilast monotherapy.
    Krishnamoorthy G; Kotecha A; Pimentel J
    BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30709830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longterm (52-week) results of a phase III randomized, controlled trial of apremilast in patients with psoriatic arthritis.
    Kavanaugh A; Mease PJ; Gomez-Reino JJ; Adebajo AO; Wollenhaupt J; Gladman DD; Hochfeld M; Teng LL; Schett G; Lespessailles E; Hall S
    J Rheumatol; 2015 Mar; 42(3):479-88. PubMed ID: 25593233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.